Further Information Disclaimer
Home
Referring Centers
For Patients
Publications
disclaimer


Full Karyotype Interphase Cells Analysis

Heinz-Ulli Weier 1 , Adolf Baumgartner 1,2 , Chun-Mei Lu 1 , Cengiz Cinnioglu 3, *,

Lisa Chu 1 , Jingly F. Weier 1,2 , Tomas Escudero 3 and Santiago Munne 3

1 UC E.O. Lawrence Berkeley National Lab, Berkeley, CA; 2 UCSF, San Francisco, CA; 3 Reprogentics, LLC, South San Francisco, CA.

Early human development depends on the correct temporal and spatial expression of thousands of genes.   The presence of an extra or a missing chromosome in gametes typically leads to failed fertilization or spontaneous abortions. Many patients suffering from reduced fertility receive help in reproduction through in vitro fertilization(which increases the number of embryos available for replacement) followed by 'Preimplantation Genetic Diagnosis (PGD)'(which allows the selection of those embryos that are chromosomally normal). PGD is based on interphase cell analysis using fluorescence in situ hybridization (FISH). However, current FISH technology can only detect a limited number of chromosomal abnormalities. To overcome this limitation, we are developing a novel FISH protocol with Spectral Imaging (SIm) technology which utilizes 3 sets of 8 uniquely-labeled, chromosome-specific DNA probes in three sequential rounds of hybridization that allows the analysis of all 24 chromosomes in a single cell. Due to the high cost of SIm equipment, we will adapt this new protocol to regular fluorescence microscopes.


PGD BREAKING NEWS
2/2006 High rates of chromosome abnormalities are found in embryos from egg donors, suggesting that PGD may be recommended in egg donor cycles.
Embryo chromosome studies show high rates of abnormalities, above 50%, but most embryos studied before this study were from patients 35 and older. | Read
Reprogenetics demonstrates that patients with recurrent pregnancy loss can benefit from PGD
The objective of the study was to determine if Preimplantation Genetic Diagnosis (PGD) and transfer of chromosomally normal embryos would decrease spontaneous abortion rates in patients suffering from recurrent pregnancy loss (RPL).   |
Read
See the abstracts presented by Reprogenetics at the PGDIS meeting (London)
Microarray technology to assess gene expression profiles... |
Read

PGD DIAGNOSIS
Reprogenetics provides PGD analysis to IVF centers, including PGD of aneuploidy for advanced maternal age (such as Down syndrome), repeated IVF failure, recurrent spontaneous abortions, chromosome translocations and inversions, as well as PGD for gene defects such as Cystic fibrosis, fragile X, Myotonic Dystrophy, Thalasaemia, Tay Sachs, and others. We also provide embryologist that can perform embryo biopsy and cell processing.  
GENETIC COUNSELING FOR PATIENTS
Patients interested in PGD services could contact an IVF center for which we provide services or directly contact our genetic counselor for an in depth discussion of your case.
ASSOCIATIONS
www.IVFonline.com
www.LifeGlobal.com
www.ivflabs.com


MORE STORIES
Reprogenetics obtains a license to perform PGD in NY state for any type of PGD
Dear Colleague: In July of 2003, laboratories and assisted reproductive technology (ART) providers were notified that a New York State laboratory permit would be required for facilities performing preimplantation genetic diagnosis (PGD) on single cells derived from embryos by molecular genetic and/or cytogenetic techniques. |
Read

HOME >>>
 

Reprogenetics
© Copyright 2001 Janus Net Technology, Inc. All rights reserved.
Refering IVF Centers Home Contact Us Further Information Disclaimers about PGD